Data from non HSCT VOD Patients Treated with Defibrotide and a Treatment IND Update to be Presented at the American Society of Hematology 2013 Annual Meeting

VILLA GUARDIA (COMO), Italy, November 26, 2013 (Globe Newswire) — Gentium S.p.A. (NASDAQ: GENT) (the “Company”) today announced that an oral presentation and a poster on Defibrotide will be presented at the 55th Annual Meeting and Exposition of the American Society of Hematology to be held at the Ernst N. Morial Convention Center in New Orleans, LA, December 7-10, 2013.


Continue Reading...